Top Story

Diabetes and the heart: Top news of 2019

January 19, 2020

Top intervention news of 2019: ISCHEMIA trials, low-risk TAVR, paclitaxel debate and more

January 18, 2020
Healio and Cardiology Today compiled a list of the most-read cardiac and vascular intervention articles published in 2019. Readers were interested in results of trials…
FDA News

FDA approves CV risk indication for semaglutide

January 17, 2020
The FDA on Thursday approved a new indication for the GLP-1 receptor agonist semaglutide to reduce the risk for major adverse cardiovascular events in adults with type 2…
In the Journals

In AF, obstructive sleep apnea confers stroke risk

January 17, 2020
Among patients with atrial fibrillation, obstructive sleep apnea was an independent risk factor for major adverse CV and neurologic events, particularly stroke…
Meeting NewsPerspective

Dapagliflozin may improve lung fluid volume in HF

January 17, 2020
PHILADELPHIA — Treatment with the SGLT2 inhibitor dapagliflozin was not associated with a reduction in mean lung fluid volume among adults with HF with reduced…
More Headlines »